Clinical Trial Update: Safety and Efficacy Study of Autologus Bone Marrow Mesenchymal Stem Cells in Multiple Sclerosis [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 trial evaluating the safety and efficacy of autologous bone marrow–derived mesenchymal stem cells in people with multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Autologous bone marrow mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: University of Jordan | Conditions: Multiple Sclerosis | Phase 1, Phase 2 | Status: COMPLETED